Doxorubicin skin penetration from monoolein-containing propylene glycol formulations

International Journal of Pharmaceutics

Volumn 329, Issue 1-2, 2007, Pages 88-93

  Herai, Haluka ^a   Gratieri, Taís ^a   Thomazine, José Antônio ^a   Bentley, Maria Vitória Lopes Badra ^a   Lopez, Renata Fonseca Vianna ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Doxorubicin; Monoolein; Skin penetration; Topical delivery; Topical tumor therapy

Indexed keywords

DOXORUBICIN; GLYCEROL OLEATE; PENETRATION ENHANCING AGENT; PROPYLENE GLYCOL;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG RETENTION; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SKIN PENETRATION; STRATUM CORNEUM; SWINE;

ADMINISTRATION, TOPICAL; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GLYCERIDES; PROPYLENE GLYCOL; SKIN; SWINE;

EID: 33845596121     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.08.021     Document Type: Article

References (42)

1. Álvarez-Cédron L., Sayalero L.M., and Lanao M.J. High-performance liquid chromatographic validated assay of doxorubicin in rat plasma and tissues. J. Chromatogr. B 721 (1999) 271-278
2. Bucks D., and Maibach H.I. Occlusion does not uniformly enhance penetration in vivo. In: Bronaugh R.L., and Maibach H.I. (Eds). Percutaneous Absorption: Drugs-Cosmetics-Mechanisms-Methodology. third ed. (1999), Marcel Dekker, New York
3. Burnette R.R., and Marrero D. Comparison between the iontophoretic and passive transport of thyrotropin releasing hormone across excised nude mouse skin. J. Pharm. Sci. 75 (1986) 738-743
4. Chabner B., and Longo D. Cancer Chemotherapy and Biotherapy. third ed. (2001), Lippincott Williams and Wilkins, New York
5. Chang B.K., Guthrie T.H., Hayakawa K., and Gangarosa L.P. A pilot study of iontophoretic cisplatin chemotherapy of basal and squamous cell carcinomas of the skin. Arch. Dermatol. 129 (1993) 425-427
6. Cornwell P.A., and Barry B.W. Sesquiterpene components of volatile oils as skin penetration enhancers for the hydrophilic permeant 5-fluorouracil. J. Pharm. Pharmacol. 46 (1994) 261-269
7. de Wolf F.A., Maliepaard M., van Dorsten F., Berghuis I., Nicolay K., and de Kruijff B. Comparable interaction of doxorubicin with various acidic phospholipids results in changes of lipid order and dynamics. Biochim. Biophys. Acta 1096 (1990) 67-80
8. Delgado-Charro M.B., and Guy R.H. Characterization of convective solvent flow during iontophoresis. Pharm. Res. 11 (1994) 929-935
9. Duarte-Karim M., Ruysschaert J.M., and Hildebrand J. Affinity of adriamycin to phospholipids. A possible explanation for cardiac mitochondrial lesions. Biochem. Biophys. Res. Commun. 71 (1976) 658-663
10. Engström S. Drug delivery from cubic and other lipid-water phases. Lipid Technol. 2 (1990) 42-45
11. Esposito E., Eblovi N., Rasi S., Drechsler M., Di Gregorio G.M., Menegatti E., and Cortesi R. Lipid-based supramolecular systems for topical application: a preformulatory study. AAPS Pharm. Sci. 5 (2003) 1-14
12. Gaber M.H., Ghannam M.M., Ali S.A., and Khalil W.A. Interaction of doxorubicin with phospholipid monolayer and liposomes. Biophys. Chem. 70 (1998) 229-233
13. Ganem-Quintanar A., Quintanar-Guerrero D., Falson-Rieg F., and Buri P. Ex vivo oral mucosal permeation of lidocaine hydrochloride with sucrose fatty acid esters as absorption enhancers. Int. J. Pharm. 173 (1998) 203-210
14. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57 (1999) 727-741
15. Giannakou S.A., Dallas P.P., Rekkas D.M., and Choulis N.H. Development and in vitro evaluation of nitrendipine transdermal formulations using experimental design techniques. Int. J. Pharm. 125 (1995) 7-15
16. Goldman R., Facchinetti T., Bach D., Raz A., and Shinitzky M. A differential interaction of daunomycin, adriamycin and their derivatives with human erythrocytes and phospholipid bilayers. Biochim. Biophys. Acta 512 (1978) 254-269
17. Goormaghtigh E., Chatelain P., Caspers J., and Ruysschaert J.M. Evidence of a specific complex between adriamycin and negatively charged phospholipids. Biochim. Biophys. Acta 597 (1980) 1-14
18. Guthrie Jr. T.H., and Porubsky E.S. Successful systemic chemotherapy of advanced squamous cell arcinoma of the skin with cis-diamminedichloroplatinum III and doxorubicin. Laryngoscope 92 (1982) 1298-1299
19. Guthrie Jr. T.H., Porubsky E.S., Mcelveen L.J., and Harmon J.D. Cisplatin and doxorubicin, an effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin. Cancer 55 (1985) 1629-1632
20. Guy R.H., and Hadgraft J. Transdermal Drug Delivery. second ed. (2003), Marcel Dekker Inc., New York
21. Heywang C., Chazalet M.S.P., Mason M., and Bolard J. Orientation of anthracyclines in lipid monolayers and planar asymmetrical bilayers: a surface-enhanced resonance Raman scattering study. Biophys. J. 75 (1998) 2368-2381
22. Hsu L.R., Huang Y.B., Wu P.C., and Tsai Y.H. Percutaneous absorption of piroxicam from FAPG base through rat skin: effects of fatty acid added to FAPG base. Int. J. Pharm. 106 (1994) 1-6
23. Larrucea E., Arellano A., Santoyo S., and Ygartua P. Combined effect of oleic acid and propylene glycol on the percutaneous penetration of tenoxicam and its retention in the skin. Eur. J. Pharm. Biopharm. 52 (2001) 113-119
24. Lopes L.B., Collett J.H., and Bentley M.V. Topical delivery of cyclosporin A: a in vitro study using monoolein as a penetration enhancer. Eur. J. Pharm. Biopharm. 60 (2005) 25-30
25. Lopez R.F.V., Bentley M.V.L.B., Delgado-Charro M.B., and Guy R.H. Iontophoretic delivery of 5-aminolevulinic acid (ALA): effect of pH. Pharm. Res. 18 (2001) 311-315
26. Lopez R.F.V., Bentley M.V.L.B., Delgado-Charro M.B., and Guy R.H. Optimization of aminolevulinic acid (ALA) by iontophoresis. J. Controlled Release 88 (2003) 65-70
27. Luxenberg M.N., and Guthrei T.H. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues. Ophthamology 93 (1986) 504-510
28. Maggio B., and Lucy J. A polar-group behaviour in mixed monolayers of phodpholipids and fusogenic lipids. Biochem. J. 155 (1976) 353-364
29. Marro D., Guy R.H., and Delgado-Charro M.B. Characterization of the iontophoretic permselectivity properties of human and pig skin. J. Control. Release 70 (2001) 213-217
30. Merino V., López A., Kalia Y.N., and Guy R.H. Electrorepulsion versus electroosmosis: effect of pH on the iontophoretic flux of 5-fluorouracil. Pharm. Res. 16 (1999) 758-761
31. Moore D.J., Powis G., Richardson R.L., and Pittelkow M.R. Topical chemotherapy of intradermal Walker 256 carcinosarcoma with diaziquone and doxorubicin in the rat. Cancer Res. 45 (1985) 5466-5472
32. Murphree S.A., Murphy D., Sartorelli A.C., and Tritton T.R. Adriamycin-liposome interactions. A magnetic resonance study of the differential effects of cardiolipin on drug-induced fusion and permeability. Biochim. Biophys. Acta 691 (1982) 97-105
33. Ogiso T., Iwaki M., and Paku T. Effect of various enhancers on transdermal penetration of indomethacin and urea, and relationship between penetration parameters and enhancement factors. J. Pharm. Sci. 84 (1995) 482-488
34. Pereira G.R., Collet J.H., Garcia S.B., Thomazini J.A., and Bentley M.V.L.B. Glycerol monooleate/solvents systems for progesterone transdermal delivery: in vitro permeation and microscopic studies. Braz. J. Pharm. Sci. 38 (2002) 55-62
35. Pikal M.J. The role of electroosmotic flow in transdermal iontophoresis. Adv. Drug Del. Rev. 9 (1992) 201-237
36. Shimizu S., Katayama K., Matsukawa H., Gotoh H., Matsumoto A., Yokoyama H., Suda T., Arita M., and Jojima T. Clinical evaluation of adriamycin ointment in advanced or local recurrent breast cancer. Gan to Kagaku Ryoho. 13 (1986) 590-592
37. Speelmans G., Stafhorst R.W.H.M., Kruijff B., and Wolf F.A. Transport studies of doxurubicin in model membranes indicate a difference in passive diffusion across and binding at the outer and inner leaflets of the plama membrane. Biochemistry 33 (1994) 13761-13768
38. Tritton T.R., Murphree S.A., and Sartorelli A.C. Adriamycin: a proposal on the specificity of drug action. Biochem. Biophys. Res. Commun. 84 (1978) 802-808
39. Vilallonga F.A., and Phillips E.W. Interaction of doxorubicin with phospholipid monolayers. J. Pharm. Sci. 67 (1978) 773-775
40. Wieman T.J., Shively E.H., and Woodcock T.M. Responsiveness of metastatic basal-cell carcinoma to chemotherapy: a case report. Cancer 52 (1983) 1583-1585
41. Williams A.C., and Barry B.W. Penetration enhancers. Adv. Drug. Deliv. Rev. 56 (2004) 603-618
42. Yamada M., and Uda Y. Enhancement of percutaneous absorption of molsidomine. Chem. Pharm. Bull. 35 (1987) 3390-3398